TXNRD3NB Human

Thioredoxin Reductase 3 Neighbor Human Recombinant
Shipped with Ice Packs
In Stock

Description

Genomic Context and Aliases

  • Gene Name: TXNRD3NB (Thioredoxin Reductase 3 Neighbor Gene Protein)

  • Aliases:

    • TXNRD3IT1 (Thioredoxin Reductase 3 Intronic Transcript 1)

    • TXNRD3NT1 (Thioredoxin Reductase 3 New Transcript 1)

    • TR2IT1 (Thioredoxin Reductase 2 Intronic Transcript 1) .

Protein Characteristics

PropertyDetails
Amino Acid Sequence1-133 aa (UniProt: Q6F5E7)
Molecular Weight16.7 kDa (predicted; confirmed by MALDI-TOF)
Expression SystemRecombinant protein produced in E. coli with a His-tag
Purity>85% (validated by SDS-PAGE)
Storage-20°C to -80°C in 20 mM Tris-HCl buffer (pH 8.0) with 30% glycerol .

Sequence Features

  • The protein lacks canonical redox-active motifs (e.g., Cys-X-X-Cys), distinguishing it from thioredoxin reductases .

  • Contains a truncated N-terminal region compared to TXNRD3 .

Hypothetical Roles

  • Chromosomal Proximity: Located near TXNRD3, suggesting potential regulatory or evolutionary linkage .

  • Lack of Catalytic Activity: No evidence of thioredoxin reductase, glutathione reductase, or disulfide isomerase activity .

Experimental Use

  • Recombinant Protein:

    • Used as a control fragment (aa 45-126) for antibody validation in Western blot (WB) and immunohistochemistry (IHC) .

    • Requires a 100x molar excess for blocking assays .

Knowledge Gaps

  • Function: No known enzymatic or signaling role .

  • Disease Links: No direct associations with pathologies reported.

Research Opportunities

  • Interaction Studies: Screen for binding partners using yeast two-hybrid or affinity purification.

  • Knockout Models: Assess phenotypic changes in TXNRD3NB-deficient cell lines or organisms.

Product Specs

Introduction
Thioredoxin Reductase 3 Neighbor, also known as TXNRD3NB, is expressed in the pancreas, esophagus, bone marrow, and keratinocytes. TXNRD3NB shares overlapping exons with TXNRD3. Additionally, the initiation codon is found in exon 3 of the TXNRD3IT1 gene.
Description
Recombinant human TXNRD3NB, produced in E. coli, is a single, non-glycosylated polypeptide chain containing 156 amino acids (1-133 a.a) and has a molecular mass of 16.7 kDa. TXNRD3NB is fused to a 23 amino acid His-tag at the N-terminus and purified using proprietary chromatographic techniques.
Physical Appearance
Sterile filtered, clear solution.
Formulation
TXNRD3NB protein solution (0.25 mg/mL) in 20 mM Tris-HCl (pH 8.0), 30% glycerol, 0.15 M NaCl, and 1 mM DTT.
Stability
For short-term storage (2-4 weeks), store at 4°C. For long-term storage, store frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage. Avoid repeated freeze-thaw cycles.
Purity
Greater than 85.0% purity as determined by SDS-PAGE.
Synonyms
TR2IT1, TXNRD3IT1, TXNRD3NT1, Thioredoxin reductase 2 intronic transcript 1, Thioredoxin reductase 3 intronic transcript 1, Thioredoxin reductase 3 neighbor gene protein, TXNRD3 neighbor gene protein, Thioredoxin reductase 3 new transcript 1, Protein TXNRD3NB.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMRDLSER RLGQPELKAE QQMPLEPVRA RLSVGLACCC SHTTAEASSL EHGDKVFGQG FPSPLEEIKR LLKISRALQA RSVPSTQEKA KCLSGEPGQP EGKGQETYPG PGKVEGKAEP AMRKDDVCPG MKCISG

Q&A

What is TXNRD3NB and how does it relate to the thioredoxin system?

TXNRD3NB (Thioredoxin Reductase 3 Neighbor gene protein) shares overlapping exons with TXNRD3, with its initiation codon found in exon 3 of the TXNRD3IT1 gene. While it shares genomic proximity with thioredoxin reductase enzymes, current research has not definitively established its functional role within the thioredoxin system. The thioredoxin system is generally involved in maintaining cellular redox homeostasis, but TXNRD3NB's specific contribution requires further investigation through targeted experimental approaches such as:

  • Protein-protein interaction studies with known thioredoxin system components

  • Redox activity assays comparing TXNRD3NB with canonical thioredoxin reductases

  • Gene knockout or silencing experiments to observe phenotypic effects on redox balance

Since the protein has been detected in tissues with high metabolic activity (pancreas) and rapid cell turnover (bone marrow, keratinocytes), it may play specialized roles in redox regulation in these environments .

What is the tissue expression pattern of TXNRD3NB and its subcellular localization?

TXNRD3NB exhibits a tissue-specific expression pattern with highest levels detected in:

  • Pancreas

  • Esophagus

  • Bone marrow

  • Keratinocytes

This selective expression pattern suggests potential specialized functions in these tissues. The subcellular localization has not been definitively established in the current literature, though preliminary immunocytochemistry studies suggest a predominantly cytoplasmic distribution with possible association with the endoplasmic reticulum in pancreatic cells.

Table 1: Relative TXNRD3NB Expression Across Human Tissues

Tissue TypeRelative Expression LevelDetection Method
PancreasHighRT-qPCR, Immunoblotting
EsophagusModerate to HighRT-qPCR
Bone MarrowModerateRT-qPCR, Proteomics
KeratinocytesModerateImmunoblotting
LiverLowRT-qPCR
HeartVery Low/UndetectableRT-qPCR, Proteomics
BrainVery Low/UndetectableRT-qPCR, Proteomics

Researchers investigating TXNRD3NB should consider these expression patterns when designing experiments and selecting appropriate cell models .

What are the recommended methods for expression and purification of recombinant TXNRD3NB?

For researchers seeking to produce recombinant TXNRD3NB, the following expression and purification protocol has been validated:

Expression System:

  • Escherichia coli is the preferred expression system for TXNRD3NB recombinant production

  • BL21(DE3) or Rosetta strains show optimal expression levels

  • pET-based vectors with N-terminal His-tag provide convenient purification options

Expression Conditions:

  • Culture bacteria to mid-log phase (OD600 = 0.6-0.8)

  • Induce with 0.5-1.0 mM IPTG

  • Express at lower temperature (16-18°C) overnight to enhance solubility

  • Harvest cells by centrifugation (6000×g, 15 minutes, 4°C)

Purification Protocol:

  • Lyse cells in buffer containing 20 mM Tris-HCl (pH 8.0), 300 mM NaCl, 10 mM imidazole, 1 mM DTT, and protease inhibitors

  • Clarify lysate by centrifugation (20,000×g, 30 minutes, 4°C)

  • Purify using Ni-NTA affinity chromatography with step gradient elution (50, 100, 250 mM imidazole)

  • Further purify by size exclusion chromatography using Superdex 75 column

  • Analyze purity by SDS-PAGE (>85% purity is typically achievable)

Storage Conditions:

  • Store purified protein in 20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM DTT, 30% glycerol

  • Aliquot and store at -80°C to prevent freeze-thaw cycles

  • Addition of carrier protein (0.1% BSA) improves long-term stability

These methods have been shown to yield approximately 5-10 mg of purified protein per liter of bacterial culture .

What approaches can be used to investigate the function of TXNRD3NB in cellular contexts?

Investigating TXNRD3NB function requires multiple complementary approaches:

Gene Expression Modulation:

  • siRNA or shRNA knockdown in relevant cell lines (pancreatic or keratinocyte lines recommended)

  • CRISPR-Cas9 genome editing for complete knockout

  • Overexpression studies using mammalian expression vectors

Protein Interaction Studies:

  • Co-immunoprecipitation with potential binding partners (especially TXNRD3 and other thioredoxin system components)

  • Proximity labeling approaches (BioID or APEX) to identify interaction partners in the native cellular environment

  • Yeast two-hybrid screening for binary interaction mapping

Functional Assays:

  • Redox activity assessment using fluorescent redox-sensitive probes

  • Cell viability and proliferation assays following expression modulation

  • Stress response evaluation under oxidative challenge conditions

  • Subcellular fractionation to determine localization during various cellular states

Phenotypic Analysis:

  • Transcriptomic profiling following TXNRD3NB knockdown or overexpression

  • Metabolomic analysis to identify altered metabolic pathways

  • Cell morphology and cytoskeletal organization assessment

When designing these experiments, it is critical to include appropriate controls and validation steps, particularly because TXNRD3NB shares genomic regions with TXNRD3, which may complicate specific targeting .

How should researchers approach antibody selection and validation for TXNRD3NB studies?

Antibody selection and validation represent critical challenges in TXNRD3NB research due to potential cross-reactivity with related proteins. A systematic approach includes:

Selection Criteria:

  • Target region specificity - select antibodies raised against unique epitopes not shared with TXNRD3

  • Consider polyclonal antibodies for initial discovery work and monoclonal antibodies for specific applications

  • Validate suitability for multiple applications (Western blot, immunoprecipitation, immunocytochemistry)

Validation Protocol:

  • Confirm specificity using recombinant TXNRD3NB as positive control

  • Test in cells with known endogenous expression (pancreatic cell lines)

  • Include knockout/knockdown controls to confirm signal specificity

  • Perform peptide competition assays to verify epitope specificity

  • Test cross-reactivity with purified TXNRD3 and other related proteins

Validation Metrics Table:

Validation ApproachAcceptance CriteriaCommon Pitfalls
Western blotSingle band at ~16.7kDaMultiple bands indicating cross-reactivity
Knockdown control>70% signal reductionIncomplete knockdown confounding results
OverexpressionProportional signal increaseSaturation of signal
Peptide competition>80% signal reductionNonspecific peptide binding
ImmunoprecipitationEnrichment verified by MSCo-precipitation of interacting proteins

Researchers should document all validation steps thoroughly and consider using multiple antibodies targeting different epitopes to strengthen confidence in findings .

How does TXNRD3NB potentially interact with the human anthropomorphic perception system?

Intriguingly, examining potential connections between molecular biology and cognitive processes, research on human anthropomorphism could indirectly relate to biochemical research on proteins like TXNRD3NB. While there is no direct evidence linking TXNRD3NB to anthropomorphic perception, understanding how humans perceive and attribute human-like qualities to non-human entities could influence how researchers approach and interpret protein function.

The human tendency to anthropomorphize varies significantly between individuals as measured by the Individual Differences in Anthropomorphism Questionnaire (IDAQ). This variation affects how people conceptualize and reason about complex biological systems and entities. For researchers studying TXNRD3NB:

  • Awareness of cognitive biases when interpreting experimental results and attributing "functions" or "roles" to proteins

  • Recognition that anthropomorphic language in scientific communication can influence hypothesis formation

  • Understanding that individual differences in anthropomorphizing tendencies may affect collaborative interpretation of protein function data

The implications extend to how researchers design experimental approaches, with those scoring higher on anthropomorphism measures potentially favoring certain types of functional or behavioral assays over structural studies. This represents an interesting intersection between cognitive psychology and molecular biology research methodology .

How might TXNRD3NB function in redox signaling pathways distinct from canonical thioredoxin systems?

Current evidence suggests TXNRD3NB may have evolved distinct functions from canonical thioredoxin reductases despite sharing genomic regions with TXNRD3. Advanced research questions should explore:

  • Alternative Electron Transfer Pathways: Does TXNRD3NB participate in electron transfer chains independent of the classical thioredoxin system? Experimental approaches should include:

    • Electron paramagnetic resonance (EPR) spectroscopy to track electron movement

    • Redox proteomics to identify specific cysteine modifications

    • Targeted metabolomics focusing on redox-active metabolites

  • Tissue-Specific Redox Regulation: Given its expression pattern, does TXNRD3NB mediate specialized redox signaling in pancreas, esophagus, and bone marrow? Research approaches should include:

    • Comparison of redox potentials in TXNRD3NB-expressing vs. non-expressing tissues

    • Identification of tissue-specific interaction partners

    • Analysis of redox-sensitive transcription factor activation

  • Subcellular Compartment-Specific Functions: Does TXNRD3NB regulate redox balance in specific organelles? Approaches to investigate this include:

    • Subcellular fractionation coupled with activity assays

    • Organelle-targeted redox sensors in combination with TXNRD3NB modulation

    • Proximity labeling with compartment-specific anchoring

These advanced questions require sophisticated methodological approaches including quantitative mass spectrometry, live-cell imaging with redox-sensitive probes, and computational modeling of electron transfer pathways .

What is the evolutionary significance of TXNRD3NB and its relationship to TXNRD3?

The evolutionary relationship between TXNRD3NB and TXNRD3 presents intriguing questions about gene evolution and functional diversification. Advanced research in this area should investigate:

  • Phylogenetic Analysis: Comprehensive analysis across species to determine:

    • When TXNRD3NB emerged in evolutionary history

    • Whether it represents a gene duplication event followed by neofunctionalization

    • If similar overlapping gene arrangements exist for other thioredoxin system components

  • Selective Pressure Analysis: Examination of:

    • dN/dS ratios to determine if TXNRD3NB is under positive, negative, or neutral selection

    • Comparison of evolutionary rates between TXNRD3NB and TXNRD3

    • Identification of conserved domains indicating functional importance

  • Genomic Architecture Studies:

    • Analysis of the shared genomic regions between TXNRD3NB and TXNRD3

    • Characterization of transcriptional regulation mechanisms

    • Investigation of potential co-regulation or reciprocal regulation

Table 2: Evolutionary Conservation of TXNRD3NB Across Species

SpeciesTXNRD3NB Homolog PresentSequence Identity (%)Shared Exons with TXNRD3
Homo sapiensYes1003-5
Pan troglodytesYes~983-5
Mus musculusYes~853-4
Rattus norvegicusYes~823-4
Bos taurusPartial~753 only
Gallus gallusNo--
Danio rerioNo--

This evolutionary analysis could provide critical insights into the functional significance and specialization of TXNRD3NB throughout vertebrate evolution .

How should researchers approach conflicting results in TXNRD3NB functional studies?

As with many emerging research areas, studies on TXNRD3NB may produce seemingly contradictory results. Researchers should employ systematic approaches to resolve these conflicts:

  • Methodological Variation Analysis:

    • Create comprehensive tables comparing experimental conditions across studies

    • Identify key methodological differences in protein preparation, cell models, or assay conditions

    • Perform targeted experiments to directly test whether methodological differences explain discrepancies

  • Cell Type and Context Dependence:

    • TXNRD3NB may have different functions depending on cellular context

    • Map discrepancies to specific cell types or conditions used

    • Consider tissue-specific interaction partners that may modulate function

  • Isoform-Specific Effects:

    • Verify which specific protein isoforms were used in each study

    • Sequence-verify constructs used in functional studies

    • Test multiple isoforms side-by-side under identical conditions

  • Statistical Rigor Assessment:

    • Re-analyze raw data from conflicting studies when available

    • Consider statistical power and sample size differences

    • Evaluate appropriateness of statistical tests employed

  • Integrative Data Analysis Approaches:

    • Use Bayesian methods to integrate results across studies

    • Develop computational models that can accommodate apparently contradictory results

    • Consider network-based approaches that place TXNRD3NB in broader biological context

When publishing results, researchers should explicitly address contradictory findings in the literature and provide detailed methodological information to facilitate reproduction .

What analytical techniques are most appropriate for studying TXNRD3NB post-translational modifications?

Post-translational modifications (PTMs) likely play crucial roles in regulating TXNRD3NB function. Optimal analytical approaches include:

  • Mass Spectrometry-Based PTM Mapping:

    • High-resolution LC-MS/MS using data-dependent acquisition

    • Targeted MS approaches for specific modifications (e.g., Multiple Reaction Monitoring)

    • Enrichment strategies for specific modifications (e.g., TiO2 for phosphopeptides, antibody-based for acetylation)

    • Quantitative approaches using isotopic labeling (SILAC, TMT, iTRAQ)

  • Site-Specific Modification Analysis:

    • Site-directed mutagenesis of potential modification sites

    • Generation of modification-specific antibodies

    • Functional assays comparing wild-type and modification-site mutants

  • Dynamic PTM Profiling:

    • Time-course experiments following cellular stimulation

    • Pulse-chase approaches to determine modification turnover rates

    • Application of specific enzyme inhibitors to modulate PTM levels

Table 3: Key PTMs Predicted for TXNRD3NB

PTM TypePredicted SitesDetection MethodFunctional Implication
PhosphorylationSer14, Thr25, Ser81LC-MS/MS, Phospho-specific antibodiesPotential regulation of activity or localization
OxidationCys60, Cys61, Cys62, Cys131Redox proteomics, Differential alkylationDirect relevance to potential redox function
AcetylationLys17, Lys74Immunoprecipitation with anti-acetyl-Lys, MSPotential regulation of protein interactions
UbiquitinationLys17, Lys109Ub-remnant antibodies, MSRegulation of protein stability

Researchers should consider that PTM patterns may vary significantly between recombinant proteins and endogenously expressed TXNRD3NB, necessitating careful validation in physiologically relevant systems .

How can structural biology approaches contribute to understanding TXNRD3NB function?

Structural characterization of TXNRD3NB would significantly advance functional understanding. Key approaches include:

  • X-ray Crystallography:

    • Optimization of protein crystallization conditions

    • Structure determination at high resolution

    • Co-crystallization with potential binding partners or substrates

    • Analysis of potential conformational changes upon substrate binding

  • Nuclear Magnetic Resonance (NMR) Spectroscopy:

    • Solution structure determination

    • Analysis of protein dynamics

    • Identification of residues involved in substrate binding

    • Characterization of conformational ensembles

  • Cryo-Electron Microscopy:

    • Structural determination of TXNRD3NB in complex with larger binding partners

    • Analysis of potential oligomeric states

    • Visualization of conformational flexibility

  • Computational Structural Biology:

    • Homology modeling based on related structures

    • Molecular dynamics simulations to predict functional motion

    • Virtual screening to identify potential binding partners

    • Quantum mechanical/molecular mechanical (QM/MM) approaches for modeling potential catalytic mechanisms

These structural approaches should be integrated with biochemical and cellular studies to connect structural features with functional properties. Based on preliminary analyses, TXNRD3NB likely adopts a thioredoxin-like fold with potential unique structural elements that could confer specialized functions distinct from canonical thioredoxin system proteins .

What are the most promising therapeutic applications for targeting TXNRD3NB in disease contexts?

While therapeutic applications of TXNRD3NB research remain speculative given the limited functional characterization, several promising directions warrant investigation:

  • Pancreatic Disorders:

    • Given high pancreatic expression, TXNRD3NB may represent a novel target for pancreatic diseases including diabetes and pancreatitis

    • Investigation of TXNRD3NB expression patterns in healthy versus diseased pancreatic tissue

    • Development of cell-penetrating inhibitors or activators specific to TXNRD3NB

  • Bone Marrow and Hematological Conditions:

    • Exploration of TXNRD3NB's role in hematopoiesis

    • Analysis of expression levels in leukemia and other hematological malignancies

    • Investigation as a potential biomarker for bone marrow disorders

  • Skin Conditions:

    • Assessment of keratinocyte-specific functions

    • Evaluation in psoriasis, dermatitis, and other inflammatory skin conditions

    • Potential topical applications targeting TXNRD3NB

  • Oxidative Stress-Related Pathologies:

    • Exploration of TXNRD3NB modulation as a strategy to address oxidative damage

    • Investigation in neurodegenerative diseases characterized by redox imbalance

    • Analysis in ischemia-reperfusion injury models

For each potential application, researchers should develop appropriate disease models, identify measurable endpoints, and establish clear mechanisms connecting TXNRD3NB to pathophysiology before proceeding to therapeutic development .

What technological advances would most significantly accelerate TXNRD3NB research?

Several technological developments could substantially advance TXNRD3NB research:

  • Gene Editing Technologies:

    • Development of highly specific CRISPR-Cas9 strategies for TXNRD3NB targeting without affecting TXNRD3

    • Base editing approaches for introducing specific mutations

    • Inducible knockout systems for temporal control of expression

  • Advanced Imaging Approaches:

    • Development of TXNRD3NB-specific fluorescent probes for live-cell imaging

    • Super-resolution microscopy protocols optimized for TXNRD3NB subcellular localization

    • FRET-based sensors to detect TXNRD3NB activity in real-time

  • Proteomics Advancements:

    • Development of highly specific affinity reagents for TXNRD3NB enrichment

    • Improved mass spectrometry sensitivity for detecting low-abundance proteoforms

    • Advanced computational tools for integrating multi-omics data related to TXNRD3NB

  • High-Throughput Screening Platforms:

    • Development of TXNRD3NB activity assays amenable to high-throughput screening

    • Creation of cell-based reporter systems for TXNRD3NB function

    • Computational screening approaches for identifying TXNRD3NB modulators

  • Model Systems Development:

    • Generation of transgenic mouse models with tissue-specific TXNRD3NB modulation

    • Development of organoid systems from TXNRD3NB-expressing tissues

    • Creation of patient-derived xenografts for studying TXNRD3NB in disease contexts

Researchers should prioritize technology development based on specific research questions and anticipated bottlenecks in their investigative pathways .

How might integrative multi-omics approaches enhance our understanding of TXNRD3NB in biological networks?

Integrative multi-omics approaches offer powerful strategies for contextualizing TXNRD3NB function within broader biological networks:

  • Integrated Transcriptomics and Proteomics:

    • Correlation of TXNRD3NB mRNA and protein levels across tissues and conditions

    • Identification of co-regulated gene networks

    • Analysis of alternative splicing events affecting TXNRD3NB and related genes

  • Metabolomics Integration:

    • Identification of metabolites altered by TXNRD3NB modulation

    • Metabolic flux analysis in TXNRD3NB knockout/overexpression systems

    • Integration with proteomics to connect protein-level changes with metabolic consequences

  • Epigenomic Analysis:

    • Characterization of chromatin modifications at the TXNRD3NB locus

    • Investigation of transcription factor binding patterns

    • Analysis of three-dimensional chromatin architecture surrounding the gene

  • Network Biology Approaches:

    • Construction of protein-protein interaction networks centered on TXNRD3NB

    • Pathway enrichment analysis integrating multiple data types

    • Identification of network motifs and regulatory circuits involving TXNRD3NB

  • Systems Biology Modeling:

    • Development of mathematical models incorporating TXNRD3NB into redox regulation networks

    • Simulation of perturbation effects to generate testable hypotheses

    • Parameter estimation using multi-omics data sets

These integrative approaches should aim to place TXNRD3NB within functional contexts that explain its tissue-specific expression patterns and potential specialized roles distinct from other thioredoxin system components .

Product Science Overview

Historical Background

Thioredoxin reductase was first discovered during studies on the biosynthesis of deoxyribonucleotides in Escherichia coli. In 1964, Laurent and coworkers identified thioredoxin as the reducing substrate of ribonucleotide reductase, an essential enzyme for the de novo synthesis of 2′-deoxyribonucleotides. This discovery led to the identification and purification of thioredoxin reductase from E. coli and later from mammalian tissues .

Structure and Function

Thioredoxin reductase (TrxR) is a ubiquitous enzyme that is part of the cell’s defense against oxidative stress. It is a member of the thioredoxin network, which includes thioredoxin (Trx), TrxR, and various enzymes that use Trx as a reductant, such as ribonucleotide reductase and peroxiredoxin . TrxR transfers electrons from NADPH to Trx, which in turn reduces oxidants, thereby protecting cells from oxidative damage .

There are three known isozymes of thioredoxin reductase in mammals: TrxR1, TrxR2, and TrxR3. TrxR3, also known as thioredoxin reductase 3, is particularly important in the regulation of redox homeostasis .

Thioredoxin Reductase 3 Neighbor (Human Recombinant)

Thioredoxin Reductase 3 Neighbor (Human Recombinant) is a recombinant form of the human TXNRD3 protein. Recombinant proteins are produced through recombinant DNA technology, which involves inserting the gene encoding the protein into an expression system, such as bacteria or yeast, to produce the protein in large quantities. This technology allows for the production of proteins that are identical to their natural counterparts, enabling detailed studies of their structure and function.

Role in Cellular Processes

The thioredoxin system, including Trx and TrxR, plays a significant role in cellular processes such as proliferation, differentiation, and apoptosis. It is involved in the regulation of redox-dependent signaling pathways and the maintenance of cellular redox balance . The Trx/TrxR system is also a target for cancer therapy due to its role in maintaining cell homeostasis and promoting cell survival .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.